NCT05691478 2026-06-03A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed OsteosarcomaNational Cancer Institute (NCI)Phase 2/3 Recruiting1,122 enrolled